4//SEC Filing
Berkenblit Anna 4
Accession 0001415889-23-010828
CIK 0000855654other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 5:56 PM ET
Size
5.0 KB
Accession
0001415889-23-010828
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
Berkenblit Anna
VP & Chief Medical Officer
Transactions
- Award
Common Stock
2023-06-30$4.05/sh+3,264$13,219→ 113,935 total
Footnotes (2)
- [F1]These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2023 through June 30, 2023.
- [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001691868
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 5:56 PM ET
- Size
- 5.0 KB